by Team Small News | Oct 2, 2025 | Lupin, Pharma
Lupin, a pharmaceutical company, has announced the retirement of its Manufacturing Operations President, Rajendra Chunodkar. As a key member of the company’s leadership team, Chunodkar has played a crucial role in overseeing the manufacturing operations of the... by Team Small News | Sep 30, 2025 | Lupin, Pharma
Lupin, a global pharmaceutical company, has recently announced a significant deal with VISUfarma, a European-based ophthalmic company, worth €190 million. This acquisition is expected to play a crucial role in Lupin’s strategy to de-risk its US business and...
by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma, Sun Pharma
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant... by Team Small News | Sep 21, 2025 | Lupin, Pharma
The U.S. Food and Drug Administration (FDA) recently conducted an inspection at Lupin’s biotech facility in Pune, India. The inspection, which took place from September 8-19, 2025, was a product-specific pre-approval inspection. As a result of the inspection,... by Team Small News | Sep 19, 2025 | Lupin, Pharma
Lupin Ltd, a global pharmaceutical company, has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules. The approved capsules are available in strengths of 2.5 mg to 25... by Team Small News | Sep 18, 2025 | Lupin, Pharma
Lupin Ltd, a global pharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsules. The capsules, which will be manufactured at Lupin’s Pithampur facility in...